The estimated Net Worth of Rich S. Nelson is at least $145 Mille dollars as of 26 February 2021. Mr. Nelson owns over 60,000 units of vTv Therapeutics Inc stock worth over $145,100 and over the last 4 years he sold VTVT stock worth over $0. In addition, he makes $0 as Director at vTv Therapeutics Inc.
Richard has made over 1 trades of the vTv Therapeutics Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he bought 60,000 units of VTVT stock worth $171,600 on 26 February 2021.
The largest trade he's ever made was buying 60,000 units of vTv Therapeutics Inc stock on 26 February 2021 worth over $171,600. On average, Richard trades about 30,000 units every 0 days since 2021. As of 26 February 2021 he still owns at least 10,000 units of vTv Therapeutics Inc stock.
You can see the complete history of Mr. Nelson stock trades at the bottom of the page.
Richard Nelson serves as Director of the Company. Mr. Nelson is a Senior Vice President of Vericast Corp., which is wholly-owned by MacAndrews & Forbes Incorporated, a related party to the Company.
Rich's mailing address filed with the SEC is C/O VTV THERAPEUTICS INC., 3980 PREMIER DRIVE, SUITE 310, HIGH POINT, NC, 55450.
Over the last 9 years, insiders at vTv Therapeutics Inc have traded over $100,050 worth of vTv Therapeutics Inc stock and bought 38,545,137 units worth $116,272,024 . The most active insiders traders include Ronald O Perelman, Srinivas Akkaraju e Bros. Advisors Lp667, L.P.B.... On average, vTv Therapeutics Inc executives and independent directors trade stock every 33 days with the average trade being worth of $6,926,668. The most recent stock trade was executed by John A Fry on 28 November 2022, trading 61,000 units of VTVT stock currently worth $50,630.
vtv therapeutics is a clinical-stage pharmaceutical company focused on the discovery and development of human therapeutics to fill unmet medical needs. our mission is to utilize our innovative technology to rapidly translate the functional modulation of human proteins into safe and effective medicines. we have a pipeline of small molecule clinical and pre-clinical drug candidates for the treatment of a wide range of human diseases including central nervous system disorders, diabetes and metabolic disorders, inflammation and cancer.
vTv Therapeutics Inc executives and other stock owners filed with the SEC include: